Registration successful.
Account activated – Pending validation
Your account has been activated successfully, but we still need to validate you as a UK healthcare professional. We’ll send you an email with the result. Please note this could take up to 10 days.
In the meantime, you can enjoy access to all the latest news, events and resources on our website.
270 result(s)
Ellipta inhaler
27-11-2015
Ellipta inhaler information for UK healthcare prpfessionals including getting started, how to use the Ellipta inhaler and top tips for your patients.
Seretide
21-11-2015
Seretide product information, news and links to support UK healthcare professionals in their daily practice.
Twinrix
21-11-2015
Twinrix (Hepatitis A (inactivated) and Hepatitis B(rDNA) (HAB)vaccine (adsorbed)) - product overview, expert perspectives and further information to support UK healthcare professionals in their daily practice.
Incruse▼ Ellipta
21-11-2015
Incruse▼ (umeclidinium bromide inhalation powder) product information and resources to support UK healthcare professionals in their daily practice.
Ambirix
21-11-2015
Ambirix (hepatitis A (inactivated) and hepatitis B (rDNA) (HAB) vaccine (adsorbed)) product information to support UK healthcare professionals in their daily practice.
Sitemap
GlaxoSmithKline (GSK) UK healthcare professional website site map.
Supply
Information to be provided to Healthcare Professionals on GSK’s medicines and vaccines supply availability
Falsified Medicines Directive
Information to support UK healthcare professionals on the falsified medicines directive in relation to GSK medicines and vaccines.
Homepage
GSKpro is exclusively created for healthcare professionals to provide GSK product related information, services and support.
Therapy areas
GSK UK therapy areas page allows healthcare professionals to find GSK product information by therapy area.
COPD
Explore GSK’s portfolio of COPD products, our clinical evidence and further resources to support UK healthcare professionals.
Cost
Cost information to support commissioners and healthcare professionals when making an asthma or COPD formulary application.
Commissioning
Resources to support commissioners and healthcare professionals when making an asthma or COPD formulary application.
Clinical Evidence
Clinical evidence information to support commissioners and healthcare professionals when making an asthma or COPD formulary application.
Planning and Implementation
Information to support commissioners and healthcare professionals plan and implement an Ellipta asthma or COPD guidelines.
Setting the record straight
Read about why we (GSK) share our trials results regardless of whether they reflect positively or negatively on our medicines.
ERS 2018
Watch video highlights from this year's ERS Conference
Respiratory
A comprehensive source of GSK respiratory information and services, designed to help UK healthcare professionals support their patients
Asthma
Explore GSK’s portfolio of asthma products, our clinical evidence and further resources to help support UK healthcare professionals.
Asthma expert perspectives
Watch GSK Global Medical Experts approach key issues in asthma treatment, offering potential solutions for you and your patients
Ellipta critical error studies in asthma
Information about the benefits of GSK's Ellipta inhaler for UK healthcare professionals to support their asthma patients
Ellipta inhaler
Learn about GSK's Ellipta inhaler, our easy-to-use device including resources to help UK healthcare professionals support their patients
Ellipta critical error studies in COPD
Information about the benefits of GSK's Ellipta inhaler for UK healthcare professionals to support their COPD patients
Products
Information and links to GSK's respiratory product portfolio for UK healthcare professionals
Healthcare in your pocket
Healthcare in your pocket - Read about the work GSK is involved in with digital technology such as the development of apps like MyAsthma.
Vaccines
GSK UK information about our vaccines and disease awareness campaigns
Vaccines – frequently asked questions
Answers to frequently asked questions about GSK Vaccines
Ordering and delivery
Find out how to set up an account and start ordering GSK vaccines.
Why Ellipta
Why Ellipta video, Benefits of an easy to use device on adherence and patient outcomes for UK healthcare professionals
Seretide Accuhaler and Ventolin Accuhaler recall
Seretide Accuhaler and Ventolin Accuhaler product recall information for UK healthcare professionals
Contact us
GSK UK contact page for healthcare professionals
Request a contact
Contact us form for UK healthcare professionals to contact GSK
Report Adverse Event
Form for UK healthcare professionals to report an adverse event related to a GSK product
Havrix Monodose and Havrix Junior Monodose
Havrix Monodose and Havrix Junior Monodose product information for UK healthcare professionals.
Havrix overview
Havrix Monodose and Havrix Junior Monodose product overview including indications, efficacy and safety information for UK healthcare professionals
Twinrix overview
Indication, administration, efficacy and safety information for Twinrix.
Avamys
Avamys (fluticasone furoate) information to support UK healthcare professionals
Efficacy and safety
Anoro▼ Ellipta (umeclidinium/vilanterol) Efficacy and safety information to support UK healthcare professionals in their daily practice.
Engerix B Overview
Indication, administration, efficacy and safety information for Engerix B.
Engerix B
Indication, administration, efficacy and safety information for Engerix B - plus links to further GSK vaccine information - for UK healthcare professionals.
COPD Guidelines and Guidance
Incruse▼ (umeclidinium bromide inhalation powder) COPD guidance and guidelines to support UK healthcare professionals in their daily practice.
Efficacy and safety
Incruse Ellipta (55 mcg) + Relvar Ellipta (92/22 mcg) therapy offers your COPD patients suitable for a LAMA + ICS/LABA a straightforward and convenient treatment option.
Indications
Incruse▼ (umeclidinium bromide inhalation powder) indication information to support UK healthcare professionals in their daily practice.
Menveo
Information about meningitis ACWY and the Menveo vaccine (Meningococcal Group A, C, W135 and Y conjugate vaccine) for UK healthcare professionals.
Menveo overview
Product overview for GSK's meningitis ACWY vaccine, Menveo (Meningococcal Group A, C, W135 and Y conjugate vaccine), including indication, administration and safety information.
Guidelines
This page is currently under review.
Toctino▼
Toctino (alitretinoin) information and resources to support UK healthcare professionals in their daily practice.
Living with severe chronic hand eczema
This page is currently under review.
Pregnancy prevention programme
Toctino (alitretinoin) pregnancy prevention programme information and resources to support UK healthcare professionals in their daily practice.
Products
GSK product information for UK healthcare professionals
Ambirix overview
Indication, administration, efficacy and safety information for Ambirix.
Administration and storage
Varilrix – Chickenpox/varicella vaccine administration and storage information to support UK healthcare professionals
Indications and dosage
Varilrix – Chickenpox/varicella vaccine indications and dosage information to support UK healthcare professionals
Efficacy and effectiveness
Varilrix – Chickenpox/varicella vaccine efficacy and effectiveness information to support UK healthcare professionals
Varilrix
Varilrix – Chickenpox/varicella vaccine product information to support UK healthcare professionals
Safety
Varilrix – Chickenpox/varicella vaccine safety information to support UK healthcare professionals
Fluarix Tetra▼
Fluarix Tetra▼ (Influenza vaccine (split virion, inactivated)) - product information to support UK healthcare professionals in their daily practice.
Fluarix Tetra FAQs
Answers to frequently asked questions about Fluarix Tetra.
Mode of action
Bexsero Meningitis B vaccine mode of action information for UK healthcare professionals
Invasive Meningococcal Disease
Bexsero Meningitis B vaccine information for healthcare professionals about Invasive Meningococcal Disease (IMD)
Population at risk
Bexsero (Men B vaccine) information for UK healthcare professionals on population at risk of Men B- infants, adolescents, patients with underlying medical conditions
Epidemiology
Bexsero Men B vaccine information for healthcare professionals about Invasive Meningococcal Disease (IMD) epidemiology
Transmission and symptoms
Bexsero Meningitis B vaccine transmission and symptoms information for UK healthcare professionals
Bexsero
Bexsero Meningitis B vaccine information for UK healthcare professionals
Indication and administration
Bexsero Meningitis B vaccine indications, administration and safety information for UK healthcare professionals
List price reduction
Learn about the list price reductions on some packs of the Seretide range
Clinical evidence
Clinical evidence to support UK Healthcare professionals in the use of Seretide for asthma and COPD.
Seretide in younger patients
Find out how Seretide could be used to treat the symptoms of asthma in paediatric patients aged four and above.
Why Seretide?
Find out about the benefits of prescribing Seretide for your asthma/COPD patients.
Seretide inhaler technique and safety
Videos and materials to help you ensure your patients are using their Seretide Accuhaler and Evohaler correctly.
Seretide rebates and savings
Learn about the immediate savings you could make by signing up to our Seretide rebate.
Adartrel
Adartrel (ropinirole hydrochloride) - links to the summary of product characteristics, patient information leaflet and supply information to support UK healthcare professionals.
How to prescribe
An overview of Duac 5% and Duac 3% formulation, strength, indications and how to prescribe Duac
Guidelines
An overview of the EDF guideline recommendations and the role of Duac in the treatment of acne
Duac
Duac product information including the latest on supply, as well resources to help support healthcare professionals and their patients <br> <Dermatology>
Trelegy▼ Ellipta
Trelegy▼ Ellipta (fluticasone furoate / umeclidinium / vilanterol) product information & resources to support UK healthcare professionals in their daily practice.
Efficacy and safety
Trelegy▼ Ellipta (fluticasone furoate / umeclidinium / vilanterol) efficacy and safety information to support UK healthcare professionals.
Quality of Life (FULFIL)
Trelegy Ellipta is a Triple Therapy for appropriate patients with COPD.
Lung Function (FULFIL)
Trelegy Ellipta is a Triple Therapy for appropriate patients with COPD.
Quality of Life (IMPACT)
Trelegy Ellipta is a Triple Therapy indicated for maintenance treatment in adult patients with moderate-to-severe chronic obstructive pulmonary disease (COPD) who are not adequately treated by a combination of an ICS and a LABA.
Efficacy
Trelegy Ellipta is a Triple Therapy indicated for maintenance treatment in adult patients with moderate-to-severe chronic obstructive pulmonary disease (COPD) who are not adequately treated by a combination of an ICS and a LABA.
Lung Function (IMPACT)
Trelegy Ellipta is a Triple Therapy indicated for maintenance treatment in adult patients with moderate-to-severe chronic obstructive pulmonary disease (COPD) who are not adequately treated by a combination of an ICS and a LABA.
Exacerbations (IMPACT)
Trelegy Ellipta is a Triple Therapy indicated for maintenance treatment in adult patients with moderate-to-severe chronic obstructive pulmonary disease (COPD) who are not adequately treated by a combination of an ICS and a LABA.
Exacerbations (FULFIL)
Trelegy Ellipta is a Triple Therapy for appropriate patients with COPD.
Formulary support
Trelegy▼ Ellipta (fluticasone furoate / umeclidinium / vilanterol) formulary support information to support UK healthcare professionals.
AeroChamber Plus
The distribution of AeroChamberPlus* has transferred from GSK UK Ltd to Trudell Medical UK as of 21st December 2017.
Amoxil
Information on the discontinuation of Amoxil and Amoxil capsules for UK healthcare professionals
No results. Why not try:
- Checking the spelling of the search term
- Trying a different search term
- Resetting or revising the filter settings (if you used filters to do this search)
Show more
Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard or search for MHRA Yellowcard in the Google Play or Apple App store. Adverse events should also be reported to GlaxoSmithKline on 0800 221 441.
